WASHINGTON, Nov. 10, 2021 /PRNewswire/ -- Vanda
Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that
Vanda management will participate at the following upcoming
investor conferences in November
2021:
The Stifel 2021 Virtual Healthcare Conference on Monday, November 15, 2021. A corporate
presentation is scheduled for 10:00 a.m.
Eastern Time.
The Jefferies 2021 London Healthcare Conference on November 18-19, 2021. An on-demand fireside chat
will be available beginning Thursday,
November 18, 2021 at 8:00 a.m.
Greenwich Mean Time (3:00 a.m. Eastern
Time).
The corporate presentation and fireside chat for the Stifel and
Jefferies conferences, respectively, may be accessed on Vanda's
corporate website, www.vandapharma.com. Investors should click on
the Investors tab and follow the links under Recent Events.
Investors are advised to go to the conference websites at least 15
minutes early to register, download, and install any necessary
software or presentations. Links to the archived conferences will
be available on Vanda's website for a period of approximately 30
days.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on
the development and commercialization of innovative therapies to
address high unmet medical needs and improve the lives of patients.
For more on Vanda Pharmaceuticals Inc., please visit
www.vandapharma.com and follow us on Twitter @vandapharma.
Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
(202) 734-3400
pr@vandapharma.com
Elizabeth Van Every
Head of Corporate Affairs
Vanda Pharmaceuticals Inc.
(202) 734-3400
pr@vandapharma.com
View original
content:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-november-2021-investor-conferences-301421716.html
SOURCE Vanda Pharmaceuticals Inc.